Abstract
There is not enough data on the effect of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) on lung involvement in patients with COVID-19 pneumonia and hypertens...
Funding Information
  • The authors have no funding to report

This publication has 22 references indexed in Scilit: